136 related articles for article (PubMed ID: 2991105)
1. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
Kiyosawa K; Daemer RJ; He LF; Bonino F; Prozesky OW; Purcell RH
Hepatology; 1985; 5(4):548-55. PubMed ID: 2991105
[TBL] [Abstract][Full Text] [Related]
2. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients.
Chen YM; Hu CP; Chen PH; Chu MH; Tsai YT; Lee SD; Chang CM
Hepatology; 1988; 8(3):547-52. PubMed ID: 2836290
[TBL] [Abstract][Full Text] [Related]
3. Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA.
Wen YM; Mitamura K; Merchant B; Tang ZY; Purcell RH
Infect Immun; 1983 Mar; 39(3):1361-7. PubMed ID: 6301993
[TBL] [Abstract][Full Text] [Related]
4. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
[TBL] [Abstract][Full Text] [Related]
5. Diversity of antinuclear antibody responses in hepatocellular carcinoma.
Covini G; von Mühlen CA; Pacchetti S; Colombo M; Chan EK; Tan EM
J Hepatol; 1997 Jun; 26(6):1255-65. PubMed ID: 9210612
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
Wong LY; Chan SH; Oon CJ
Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
[TBL] [Abstract][Full Text] [Related]
7. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatitis B surface antigen in human hepatoma-derived cell lines.
Oefinger PE; Bronson DL; Dreesman GR
J Gen Virol; 1981 Mar; 53(Pt 1):105-13. PubMed ID: 6268737
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
Tabor E; Kim CM
J Med Virol; 1991 May; 34(1):45-50. PubMed ID: 1715897
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma.
Lok AS; Ma OC
Hepatology; 1990 Sep; 12(3 Pt 1):582-8. PubMed ID: 2169455
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluation.
Matter L; Schopfer K; Wilhelm JA; Nyffenegger T; Parisot RF; De Robertis EM
Arthritis Rheum; 1982 Nov; 25(11):1278-83. PubMed ID: 6753854
[TBL] [Abstract][Full Text] [Related]
12. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma.
Hsu HC; Wu TT; Sheu JC; Wu CY; Chiou TJ; Lee CS; Chen DS
Hepatology; 1989 May; 9(5):747-50. PubMed ID: 2540083
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma.
Govindarajan S; Hevia FJ; Peters RL
Cancer; 1984 Apr; 53(8):1692-4. PubMed ID: 6321013
[TBL] [Abstract][Full Text] [Related]
14. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.
Shouval D; Eilat D; Carlson RI; Adler R; Livni N; Wands JR
Hepatology; 1985; 5(3):347-56. PubMed ID: 2987098
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B antigen and auto-antibodies in chronic liver diseases in Hong Kong.
Lee AK
Aust N Z J Med; 1975 Jun; 5(3):235-9. PubMed ID: 169780
[TBL] [Abstract][Full Text] [Related]
17. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.
Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217
[TBL] [Abstract][Full Text] [Related]
18. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes.
Ackerman Z; Wands JR; Gazitt Y; Brechot C; Kew MC; Shouval D
J Hepatol; 1994 Mar; 20(3):398-404. PubMed ID: 8014453
[TBL] [Abstract][Full Text] [Related]
20. Electron microscopy of HBsAg from human hepatoma cell line.
Lancet; 1977 Oct; 2(8040):713-4. PubMed ID: 71521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
